abstract |
The present invention relates to novel biaryl derivatives of formula (I) and physiologically acceptable salts thereof, wherein formula (A), m, R 1 , R 2 , R 3 , X 1 , X 2 and X 3 are As defined in the specification and claims. Such compounds are antagonists of the CCR-2 receptor, CCR-5 receptor and / or CCR-3 receptor and can be used as medicaments. Formula I Formula (A) |